Bupropion Hydrochloride Tablet
NDC 67046-1672
Product Information
Bupropion Hydrochloride is a ANDA-approved product labeled by Coupler Llc. This medication is typically used as a aminoketone [epc]. It is supplied as a red tablet for oral administration. This product entry covers the primary NDC 67046-1672 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
192
Code Structure Chart
Product Details
What is NDC 67046-1672?
What are Active Ingredients of this product?
- BUPROPION HYDROCHLORIDE 100 mg/1 - A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- BUPROPION HYDROCHLORIDE (UNII: ZG7E5POY8O)
- BUPROPION (UNII: 01ZG3TPX31) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
- HYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)
- STARCH, CORN (UNII: O8232NY3SJ)
- POTASSIUM CHLORIDE (UNII: 660YQ98I10)
- HYPROMELLOSES (UNII: 3NXW29V3WO)
- STEARIC ACID (UNII: 4ELV7Z65AP)
- POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)
- POLYSORBATE 80 (UNII: 6OZP39ZG8H)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- TRIACETIN (UNII: XHX3C3X673)
- FD&C RED NO. 40 ALUMINUM LAKE (UNII: 6T47AS764T)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 993687 - buPROPion HCl 100 MG Oral Tablet
- RxCUI: 993687 - bupropion hydrochloride 100 MG Oral Tablet
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.